Microvascular and macrovascular complications in children and adolescents
暂无分享,去创建一个
R. Wadwa | L. Dimeglio | M. Marcovecchio | F. Chiarelli | M. Craig | K. Donaghue | P. Hofman | J. Raza | Mona A. Salem | T. Wong | T. Wong | T. Wong
[1] Tien Yin Wong,et al. Kidney and eye diseases: common risk factors, etiological mechanisms, and pathways. , 2014, Kidney international.
[2] L. E. Lovblom,et al. Does the Prevailing Hypothesis That Small-Fiber Dysfunction Precedes Large-Fiber Dysfunction Apply to Type 1 Diabetic Patients? , 2014, Diabetes Care.
[3] M. Craig,et al. Puberty as an accelerator for diabetes complications , 2014, Pediatric diabetes.
[4] F. Kardelen,et al. Investigation of endothelial dysfunction and arterial stiffness in children with type 1 diabetes mellitus and the association with diastolic dysfunction , 2014, Diabetes & vascular disease research.
[5] F. Wolf. Standards of Medical Care in Diabetes—2014 , 2013, Diabetes Care.
[6] Jasmin Divers,et al. Peripheral Neuropathy in Adolescents and Young Adults With Type 1 and Type 2 Diabetes From the SEARCH for Diabetes in Youth Follow-up Cohort , 2013, Diabetes Care.
[7] Wei-Chih Liao,et al. Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis , 2013, BMJ.
[8] E. Wiltshire,et al. Folate fortification and supplementation do not provide vascular health benefits in type 1 diabetes. , 2013, The Journal of pediatrics.
[9] M. Craig,et al. Autonomic neuropathy in young people with type 1 diabetes: a systematic review , 2013, Pediatric diabetes.
[10] A. Sjølie,et al. Is Smoking a Risk Factor for Proliferative Diabetic Retinopathy in Type 1 Diabetes? , 2013, Ophthalmologica.
[11] B. Klein,et al. Assessing Progress in Retinopathy Outcomes in Type 1 Diabetes , 2013, Diabetes Care.
[12] R. Beck,et al. Most Youth With Type 1 Diabetes in the T1D Exchange Clinic Registry Do Not Meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes Clinical Guidelines , 2013, Diabetes Care.
[13] J. Craig,et al. Antihypertensive agents for preventing diabetic kidney disease. , 2012, The Cochrane database of systematic reviews.
[14] J. Baldi,et al. Diastolic Function Is Reduced in Adolescents With Type 1 Diabetes in Response to Exercise , 2012, Diabetes Care.
[15] G. Simonetti,et al. Pregnancy Outcome Following Exposure to Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Antagonists: A Systematic Review , 2012, Hypertension.
[16] P. Baghurst,et al. Hypoglycemia, but not glucose variability, relates to vascular function in children with type 1 diabetes. , 2012, Diabetes technology & therapeutics.
[17] Hong Huang,et al. Hyperglycemia Increases Muscle Blood Flow and Alters Endothelial Function in Adolescents with Type 1 Diabetes , 2012, Experimental diabetes research.
[18] B. Klein,et al. Global Prevalence and Major Risk Factors of Diabetic Retinopathy , 2012, Diabetes Care.
[19] M. Craig,et al. Microvascular complications assessment in adolescents with 2‐ to 5‐yr duration of type 1 diabetes from 1990 to 2006 , 2011, Pediatric diabetes.
[20] M. Rewers,et al. Obesity and coronary artery calcium in diabetes: the Coronary Artery Calcification in Type 1 Diabetes (CACTI) study. , 2011, Diabetes technology & therapeutics.
[21] R. Hoffmann,et al. Impaired Endothelial Function in Preadolescent Children With Type 1 Diabetes , 2011, Diabetes Care.
[22] Rayaz A. Malik,et al. Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments , 2010, Diabetes Care.
[23] R. G. Miller,et al. In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study , 2010, Diabetologia.
[24] J. Baldi,et al. Effect of reduced total blood volume on left ventricular volumes and kinetics in type 2 diabetes , 2010, Acta physiologica.
[25] S. Daniels,et al. Prevalence of increased arterial stiffness in children with type 1 diabetes mellitus differs by measurement site and sex: the SEARCH for Diabetes in Youth Study. , 2010, The Journal of pediatrics.
[26] C. Forsblom,et al. Age at Onset and the Risk of Proliferative Retinopathy in Type 1 Diabetes , 2010, Diabetes Care.
[27] Neil H. White,et al. Effect of Prior Intensive Therapy in Type 1 Diabetes on 10-Year Progression of Retinopathy in the DCCT/EDIC: Comparison of Adults and Adolescents , 2010, Diabetes.
[28] J. Couper,et al. Aortic intima media thickness is an early marker of atherosclerosis in children with type 1 diabetes mellitus. , 2010, The Journal of pediatrics.
[29] R. Klein,et al. Rates of Progression in Diabetic Retinopathy During Different Time Periods , 2009, Diabetes Care.
[30] H. Tildesley,et al. Apolipoprotein B levels in adults with type 1 diabetes not receiving lipid-lowering therapy. , 2009, Clinical biochemistry.
[31] B. Groves,et al. Cardiac dysfunction during exercise in uncomplicated type 2 diabetes. , 2009, Medicine and science in sports and exercise.
[32] Merlin C. Thomas,et al. The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes , 2009, Diabetes.
[33] R. Danielsen,et al. Factors contributing to left ventricular diastolic dysfunction in long-term type I diabetic subjects. , 2009, Acta medica Scandinavica.
[34] K. Borch-Johnsen,et al. Cardiovascular risk factors in type I (insulin-dependent) diabetic patients with and without proteinuria. , 2009, Acta medica Scandinavica.
[35] J. Todd,et al. Ambulatory blood pressure measurements are related to albumin excretion and are predictive for risk of microalbuminuria in young people with type 1 diabetes , 2009, Diabetologia.
[36] R. Wadwa,et al. Lipid and Lipoprotein Profiles in Youth With and Without Type 1 Diabetes , 2008, Diabetes Care.
[37] S. Twigg,et al. Timing Is Everything: Age of Onset Influences Long-Term Retinopathy Risk in Type 2 Diabetes, Independent of Traditional Risk Factors , 2008, Diabetes Care.
[38] M. Craig,et al. Role of blood pressure in development of early retinopathy in adolescents with type 1 diabetes: prospective cohort study , 2008, BMJ : British Medical Journal.
[39] J. Baldi,et al. Impaired stroke volume and aerobic capacity in female adolescents with type 1 and type 2 diabetes mellitus , 2008, Diabetologia.
[40] D. Dunger,et al. Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study , 2008, BMJ : British Medical Journal.
[41] N. Øverby,et al. High prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes: a population-based study , 2008, Diabetologia.
[42] R Peto,et al. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. , 2008, Lancet.
[43] D. Maahs,et al. Higher Prevalence of Elevated Albumin Excretion in Youth With Type 2 Than Type 1 Diabetes , 2007, Diabetes Care.
[44] T. Jones,et al. Diabetes care, glycemic control, and complications in children with type 1 diabetes from Asia and the Western Pacific Region. , 2007, Journal of diabetes and its complications.
[45] T. Wong,et al. Management of diabetic retinopathy: a systematic review. , 2007, JAMA.
[46] G. Remuzzi,et al. Kidney failure stabilizes after a two-decade increase: impact on global (renal and cardiovascular) health. , 2006, Clinical journal of the American Society of Nephrology : CJASN.
[47] J. Craig,et al. Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease. , 2006, The Cochrane database of systematic reviews.
[48] F. Fazio,et al. Persistent Renal Hypertrophy and Faster Decline of Glomerular Filtration Rate Precede the Development of Microalbuminuria in Type 1 Diabetes , 2006, Diabetes.
[49] E. Wiltshire,et al. Folate and Vitamin B6 Rapidly Normalize Endothelial Dysfunction In Children With Type 1 Diabetes Mellitus , 2006, Pediatrics.
[50] N. Clark,et al. Standards of Medical Care in Diabetes: Response to Power , 2006 .
[51] B. Zinman,et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. , 2005, The New England journal of medicine.
[52] D. Maahs,et al. Total cholesterol and high-density lipoprotein levels in pediatric subjects with type 1 diabetes mellitus. , 2005, The Journal of pediatrics.
[53] D. Dunger,et al. The relationship between microalbuminuria and glomerular filtration rate in young type 1 diabetic subjects: The Oxford Regional Prospective Study. , 2005, Kidney international.
[54] S. Dib,et al. Aerobic exercise capacity in normal adolescents and those with type 1 diabetes mellitus , 2005, Pediatric diabetes.
[55] H. Parving,et al. Improved prognosis in type 1 diabetic patients with nephropathy: a prospective follow-up study. , 2005, Kidney international.
[56] M. Craig,et al. Discordant trends in microvascular complications in adolescents with type 1 diabetes from 1990 to 2002. , 2005, Diabetes care.
[57] P. Rossing. The changing epidemiology of diabetic microangiopathy in type 1 diabetes , 2005, Diabetologia.
[58] P. Crock,et al. Prevalence of diabetes complications 6 years after diagnosis in an incident cohort of childhood diabetes , 2005, Diabetic medicine : a journal of the British Diabetic Association.
[59] J. Hokanson,et al. Awareness and treatment of dyslipidemia in young adults with type 1 diabetes. , 2005, Diabetes care.
[60] M. Craig,et al. The case for biennial retinopathy screening in children and adolescents. , 2005, Diabetes care.
[61] Richard Platt,et al. Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. , 2004, JAMA.
[62] J. Craig,et al. Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review , 2004, BMJ : British Medical Journal.
[63] B. Rosner,et al. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents , 2004 .
[64] Thomas H Marwick,et al. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. , 2004, Endocrine reviews.
[65] Isabel Rey Madeira,et al. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. , 2004, Pediatrics.
[66] H. Büller,et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study , 2004, JAMA.
[67] J. Ellis,et al. Effect of mydriasis and different field strategies on digital image screening of diabetic eye disease , 2004, British Journal of Ophthalmology.
[68] D. Lackland,et al. Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort. , 2004, Investigative ophthalmology & visual science.
[69] S. Shahinfar,et al. A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of lisinopril for children with hypertension. , 2003, American journal of hypertension.
[70] P. Scanlon,et al. Comparison of two reference standards in validating two field mydriatic digital photography as a method of screening for diabetic retinopathy , 2003, The British journal of ophthalmology.
[71] D. Lackland,et al. Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy. , 2003, Kidney international.
[72] J. Olson,et al. A comparative evaluation of digital imaging, retinal photography and optometrist examination in screening for diabetic retinopathy , 2003, Diabetic medicine : a journal of the British Diabetic Association.
[73] Sarah Parish,et al. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial , 2003, The Lancet.
[74] Andrzej S Krolewski,et al. Regression of microalbuminuria in type 1 diabetes. , 2003, The New England journal of medicine.
[75] A. J. Swerdlow,et al. Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes , 2003, Diabetologia.
[76] Braxton D Mitchell,et al. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. , 2003, Diabetes care.
[77] M. Craig,et al. Do all prepubertal years of diabetes duration contribute equally to diabetes complications? , 2003, Diabetes care.
[78] D. Lackland,et al. Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia. , 2003, Diabetes care.
[79] M. Mercuri,et al. Efficacy and Safety of Statin Therapy in Children With Familial Hypercholesterolemia: A Randomized, Double-Blind, Placebo-Controlled Trial With Simvastatin , 2002, Circulation.
[80] J. Redón,et al. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. , 2002, The New England journal of medicine.
[81] Leiv Sandvik,et al. Silent coronary atheromatosis in type 1 diabetic patients and its relation to long-term glycemic control. , 2002, Diabetes.
[82] M. Blumenkranz,et al. The sensitivity and specificity of single-field nonmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: a comparison with ophthalmoscopy and standardized mydriatic color photography. , 2002, American journal of ophthalmology.
[83] S. Shahinfar,et al. A Double‐Blind, Placebo‐Controlled, Dose‐Response Study of the Effectiveness and Safety of Enalapril for Children with Hypertension , 2002, Journal of clinical pharmacology.
[84] H. Parving,et al. Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study. , 2002, Diabetes care.
[85] M. Taskinen,et al. Family histories of Type II diabetes and hypertension predict intima–media thickness in patients with Type I diabetes , 2002, Diabetologia.
[86] H. Dorchy,et al. Risk factors of developing proliferative retinopathy in type 1 diabetic patients : role of BMI. , 2002, Diabetes care.
[87] J. Fuller,et al. Factors associated with plasma lipids and lipoproteins in Type 1 diabetes mellitus: the EURODIAB IDDM Complications Study , 2001, Diabetic medicine : a journal of the British Diabetic Association.
[88] S. Twyman,et al. Longitudinal study of urinary albumin excretion in young diabetic patients–‐Wessex Diabetic Nephropathy Project , 2001, Diabetic medicine : a journal of the British Diabetic Association.
[89] N. Chaturvedi. Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data. , 2001, Annals of internal medicine.
[90] Diabetes Control. Effect of pregnancy on microvascular complications in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. , 2000, Diabetes care.
[91] C. Fortin,et al. Impact of left ventricular diastolic dysfunction on maximal treadmill performance in normotensive subjects with well-controlled type 2 diabetes mellitus. , 2000, The American journal of cardiology.
[92] G. Watts,et al. Endothelial dysfunction in Type 2 diabetic subjects with and without microalbuminuria. , 1999, Diabetic medicine : a journal of the British Diabetic Association.
[93] D. Dunger,et al. Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Oxford Regional Prospective Study Group. , 1999, Diabetes care.
[94] J M Sparrow,et al. The national diabetic retinopathy laser treatment audit III. Clinical outcomes , 1999, Eye.
[95] P. Hopkins,et al. Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial. , 1999, JAMA.
[96] T. Elhadd,et al. Elevated Plasma Vascular Endothelial Cell Growth Factor and Thrombomodulin in Juvenile Diabetic Patients , 1999, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[97] S. Greene,et al. Influence of puberty on endothelial dysfunction and oxidative stress in young patients with type 1 diabetes. , 1998, Diabetes care.
[98] Joël Ménard,et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.
[99] T. Jones,et al. Progression of borderline increases in albuminuria in adolescents with insulin‐dependent diabetes mellitus , 1997, Diabetic medicine : a journal of the British Diabetic Association.
[100] F. Ferris. Early photocoagulation in patients with either type I or type II diabetes. , 1997, Transactions of the American Ophthalmological Society.
[101] T. Danne,et al. Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects. , 1997, The Journal of pediatrics.
[102] M. Muggeo,et al. Cardiovascular disease and its risk factors in IDDM in Europe. EURODIAB IDDM Complications Study Group. , 1996, Diabetes care.
[103] M. Muggeo,et al. Cardiovascular Disease and Its Risk Factors in IDDM in Europe , 1996, Diabetes Care.
[104] S. Rudberg,et al. Determinants of Progression of Microalbuminuria in Adolescents With IDDM , 1996, Diabetes Care.
[105] H. Parving,et al. Prevention of diabetic renal disease with special reference to microalbuminuria , 1995, The Lancet.
[106] A. Donker,et al. Endothelial Dysfunction Precedes Development of Microalbuminuria in IDDM , 1995, Diabetes.
[107] N. Sharpe,et al. Comparison of echocardiographic variables between type I diabetics and normal controls. , 1995, The American journal of cardiology.
[108] J. Couper,et al. Relationship of Smoking and Albuminuria in Children with Insulin‐dependent Diabetes , 1994, Diabetic medicine : a journal of the British Diabetic Association.
[109] Diabetes Control. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group. , 1994, The Journal of pediatrics.
[110] D. Rogers,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus , 1994 .
[111] J Ludvigsson,et al. Declining incidence of nephropathy in insulin-dependent diabetes mellitus. , 1994, The New England journal of medicine.
[112] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[113] R. Ross. The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.
[114] J. Neaton,et al. Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial , 1993, Diabetes Care.
[115] R. Hamman,et al. Smokers with IDDM Experience Excess Morbidity: The Colorado IDDM Registry , 1992, Diabetes Care.
[116] H. Parving. Impact of Blood Pressure and Antihypertensive Treatment on Incipient and Overt Nephropathy, Retinopathy, and Endothelial Permeability in Diabetes Mellitus , 1991, Diabetes Care.
[117] E. Seaquist,et al. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. , 1989, The New England journal of medicine.
[118] P. Andersen,et al. The effect of proteinuria on relative mortality in Type 1 (insulin-dependent) diabetes mellitus , 1985, Diabetologia.
[119] C. Mogensen,et al. Predicting diabetic nephropathy in insulin-dependent patients. , 1984, The New England journal of medicine.
[120] K. Johansen,et al. Incipient nephropathy in Type 1 (insulin-dependent) diabetes , 1984, Diabetologia.
[121] D. DeMets,et al. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. , 1984, Archives of ophthalmology.
[122] H. Keen,et al. MICROALBUMINURIA AS A PREDICTOR OF CLINICAL NEPHROPATHY IN INSULIN-DEPENDENT DIABETES MELLITUS , 1982, The Lancet.
[123] M. Abbal,et al. FACTOR-VIII COMPLEX AND ENDOTHELIAL DAMAGE , 1975, The Lancet.
[124] S. Twigg,et al. Long-Term Complications and Mortality in Young-Onset Diabetes Type 2 diabetes is more hazardous and lethal than type 1 diabetes , 2013 .
[125] Jennifer W Talton,et al. Reduced Heart Rate Variability Among YouthWith Type 1 Diabetes The SEARCH CVD study , 2012 .
[126] D. Theriaque,et al. Pediatric Atorvastatin in Diabetes Trial (PADIT): A Pilot Study to Determine the Effect of Atorvastatin on Arterial Stiffness and Endothelial Function in Children with Type 1 Diabetes Mellitus , 2009, Journal of pediatric endocrinology & metabolism : JPEM.
[127] M. Craig,et al. The Case for Biennial Retinopathy Screening in Children and Adolescents: Response to Stefánsson , 2006 .
[128] D. Power. Standards of medical care in diabetes. , 2006, Diabetes care.
[129] D. Raev. Left ventricular function and specific diabetic complications in other target organs in young insulin-dependent diabetics: An echocardiographic study , 2005, Heart and Vessels.
[130] L. V. Van Gaal,et al. Impact of overweight on chronic microvascular complications in type 1 diabetic patients. , 2005, Diabetes care.
[131] S. Daniels,et al. Clinical and research aspects of ambulatory blood pressure monitoring in children. , 2004, The Journal of pediatrics.
[132] S. Hori. Guidelines for the Management of Diabetic Retinopathy for the Internist , 2002 .
[133] P A Cleary,et al. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). , 2001, The Journal of pediatrics.
[134] T. Sano,et al. [Diabetic retinopathy]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.
[135] Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. , 1998, Archives of ophthalmology.
[136] O. Jolobe. Angiotensin-converting enzyme inhibitors. , 1995, British journal of hospital medicine.
[137] A. Kriska,et al. Insulin-dependent diabetes mellitus, physical activity, and death. , 1993, American journal of epidemiology.
[138] J. Wetzels,et al. The changing natural history of nephropathy in type I diabetes. , 1986, The American journal of medicine.
[139] Curtis L. Meinert,et al. Photocoagulation treatment of proliferative diabetic retinopathy: the second report of diabetic retinopathy study findings. , 1978, Ophthalmology.